005500 — Samjin Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩234bn
- KR₩357bn
- KR₩309bn
Annual cashflow statement for Samjin Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 28,404 | 21,901 | 18,906 | 39,233 | 24,170 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 12,226 | 7,130 | 7,266 | 17,370 | 4,412 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -24,023 | -21,554 | -34,451 | -35,851 | -24,291 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 23,967 | 17,293 | 8,334 | 38,153 | 24,111 |
| Capital Expenditures | -74,603 | -35,498 | -20,721 | -18,338 | -14,494 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 3,047 | -34,559 | 2,472 | -28.5 | -12,376 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -71,555 | -70,057 | -18,249 | -18,366 | -26,870 |
| Financing Cash Flow Items | 300 | -200 | 102 | 13.2 | -36.4 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 36,619 | 47,165 | 9,975 | -18,770 | 11,422 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -10,969 | -5,599 | 60 | 1,016 | 8,663 |